EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus epidermidis Periprosthetic Joint Infection

Melissa T Cammuso, Bradley W M Cook iD, D William Cameron iD, Stephen Ryan, Marielou Tamayo, Melissa J Peters iD, Tia Arnaud, Stephanie Lau, Henrik Almblad iD, Nicolas Fournier, Karen LoVetri, Tasia J Lightly und 6 weitere

Viruses · 2025

DOI: 10.3390/v17081118 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Viruses, 2025. Verfasst von Melissa T Cammuso und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada. Hauptthemen laut MEDLINE: Phage Therapy, Prosthesis-Related Infections, Staphylococcal Infections, Staphylococcus epidermidis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe the first use of phage therapy in Canada for the treatment of a life-threatening periprosthetic joint infection (PJI), with successful outcome. PJI is a devastating complication of joint replacement surgery, with high morbidity and mortality. Our patient presented with early sepsis from a chronic recalcitrant multidrug-resistant (MDR) Staphylococcus epidermidis hip PJI which had repeatedly failed standard therapy. She had previously undergone 10 operations of the right hip, and only three weeks after completing a prolonged course of daptomycin following her most recent hip revision, she developed a draining sinus tract. Given the high burden of disease, inability to achieve surgical source control, and lack of antibiotic treatment options for long-term suppressive therapy, bacteriophage (phage) therapy was pursued. The patient underwent irrigation and debridement with complex flap reconstruction: intraoperative tissue cultures again yielded MDR S. epidermidis. We developed a novel phage therapy protocol for this patient, with twice daily, intra-articular and intravenous (7 × 109 PFU/dose) phage delivery over a planned 14-day course. Complete healing of the wound with cessation of drainage occurred within one month after treatment. A marked improvement in right hip pain and mobility occurred within three months after treatment. Twelve months following phage treatment, there is normalization of serum inflammatory markers with diminished pain, increased mobility, and no recurrent surgery. Our patient continues to improve and is currently living independently at home, with sustained clinical control of infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyProsthesis-Related InfectionsStaphylococcal InfectionsStaphylococcus epidermidisAgedFemaleHumansAnti-Bacterial AgentsBacteriophagesCanadaDrug Resistance, Multiple, BacterialTreatment Outcome

Stichwörter der Autor:innen

antibiotic resistanceperiprosthetic joint infectionphage therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
  • Cytophage Technologies, Ltd., Oak Bluff, MB R4G 0B1, Canada.
  • Division of Infectious Diseases, Department of Medicine, University of Ottawa at The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
  • Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
  • Department of Medical Imaging, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
  • Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

ORCID-Profile: Bradley W M Cook, D William Cameron, Melissa J Peters, Henrik Almblad, Gina A Suh, Marisa A Azad

Zitieren

APA

Cammuso, M. T., Cook, B. W. M., Cameron, D. W., Ryan, S., Tamayo, M., Peters, M. J., Arnaud, T., Lau, S., Almblad, H., Fournier, N., LoVetri, K., Lightly, T. J., Chung, Y. M., Roy, R., Theriault, N., Theriault, S. S., Suh, G. A., & Azad, M. A. (2025). First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus epidermidis Periprosthetic Joint Infection. Viruses. https://doi.org/10.3390/v17081118

Vancouver

Cammuso MT, Cook BWM, Cameron DW, Ryan S, Tamayo M, Peters MJ, et al. First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus epidermidis Periprosthetic Joint Infection. Viruses. 2025. doi:10.3390/v17081118

BibTeX
@article{Cammuso2025,
  author = {Cammuso, Melissa T and Cook, Bradley W M and Cameron, D William and Ryan, Stephen and Tamayo, Marielou and Peters, Melissa J and Arnaud, Tia and Lau, Stephanie and Almblad, Henrik and Fournier, Nicolas and LoVetri, Karen and Lightly, Tasia J and Chung, Yuen Ming and Roy, Riya and Theriault, Natasha and Theriault, Steven S and Suh, Gina A and Azad, Marisa A},
  title = {First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus epidermidis Periprosthetic Joint Infection},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17081118}
}
Kostenlos starten →